Sunnybrook Health Sciences Centre (Thromboembolism Residency Training) - Accreditation Pending

2075 Bayview Avenue
Toronto, ON, M4N 3M5

Dr. Danette Beechinor, BScPharm, PharmD
Phone: 416-480-6100 ext. 4494
Fax: 416-480-5887

Lesley Palmay, BSc, BScPhm, MSc, ACPR
Phone: 416-480-6100 ext. 87563
Fax: 416-480-5887

Lesley Palmay, BSc, BScPhm, MSc, ACPR
Phone: 416-480-6100 ext. 87563
Fax: 416-480-5887

Interested applicants:
Please submit a letter of interest and a current curriculum vitae to: Monday May 2, 2022
Danette Beechinor, Director of Pharmacy
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room 305
Toronto, ON, M4N 3M5

Type: Thromboembolism (TE)

Focus: Inpatient/Ambulatory care
Est. in: 2019
# Position(s): 1
App. Deadline: Monday May 2, 2022
Starting Date: September 2022 (flexible)
Est. stipend: $50,000 per annum
Benefits: Yes
Vacation/holiday leave: 10 paid vacation days
Education/conference leave: Yes (budget and time provided to support residents to attend conferences will be reviewed each year)

Minimum required credentials:
The Pharmacy Leaders in Thrombosis Residency will consider applicants who express an interest in and commitment to advanced practice in the area of thrombosis. The applicant will be a registered pharmacist with one of the following:

  • Doctor of Pharmacy as a second professional degree (i.e. post-baccalaureate), or
  • Master’s degree in advanced pharmacotherapy, or
  • Completion (or due to complete) an accredited year-1 Pharmacy residency.

Program Highlights: This year 2 residency program in Thromboembolism (TE) is built on the recognition that the prevention and management of thromboembolic disorders are important patient quality of care priorities for hospitalized and community patients. The program is designed to help create capacity to effectively manage patients with respect to thromboembolic disorders by training pharmacists to have the advanced clinical skills and experience to be leaders in this aspect of patient care.

The goals of this program are:

  • To foster competence in the areas of patient safety and quality improvement with specific emphasis on improving the effective and safe use of antithrombotic medications through the provision of evidence-based direct patient care as part of an inter-professional team
  • Managing components of the medication use system, pertaining to antithrombotic medications
  • Providing medication- and practice-related education to patients and other team members
  • To enhance individual skills and confidence so that the successful resident can become a thrombosis management practitioner, change agent and leader in this area locally and/or regionally
  • To develop project management and research skills through the completion of research projects in an area of relevance to thrombosis

The option of combining the residency with a Master’s degree can be considered based on the interest of the applicant.

The program will consist of:

  • A broad-based, formal curriculum designed to increase the pharmacist’s knowledge and understanding of the clinical science and operational practice of the prevention and treatment of venous and arterial thromboembolic disorders
  • Practical, clinical experience on the inpatient and outpatient thromboembolism service as well as the Cardiology and Vascular Surgery programs
  • Research in a relevant area of thrombosis practice.

Activities of the residency will also be tailored based on the needs and interests of the resident.

Required Rotations:

  1. Thromboembolism Inpatient Service
  2. Thromboembolism Outpatient Clinics
  3. Anticoagulant Management Clinic
  4. Cardiology Service
  5. Stroke Service
  6. Research

Elective Rotations: may be arranged upon the interest of the resident.


Type: Tertiary Care, Academic Teaching Hospital
Number of beds: 1,325
Site(s): Sunnybrook Health Sciences Centre, Bayview Campus
Affiliation: University of Toronto


Jennifer Pitman

Stephanie Carlin